Result of AGM

Baillie Gifford UK Growth Trust PLC
07 September 2023
 

 

Baillie Gifford UK Growth Trust plc (BGUK)

Legal Entity Identifier: 549300XX386SYWX8XW22

Additional regulated information required to be disclosed under applicable law

Annual General Meeting held on 7 September 2023

At the AGM held on 7 September 2023 all resolutions were passed, including those detailed below:

·     Shareholders approved an ordinary resolution granting the Directors' general authority to issue shares up to an aggregate nominal amount of £3,760,387, representing approximately 10% of the total issued share capital (excluding treasury shares) of the Company as at 14 June 2023. This authority will expire at the conclusion of the AGM of the Company to be held in 2024 (unless previously varied, revoked or renewed).

·     A special resolution renewing the Directors' authority to issue shares and sell treasury shares on a non pre-emptive basis up to an aggregate nominal amount of £3,760,387 (representing 10% of the total issued share capital of the Company). This authority will expire at the conclusion of the next AGM of the Company (unless previously renewed, varied or revoked by the Company in general meeting).

 

·     A special resolution renewing the Company's authority to make market purchases of up to 14.99% of the Company's issued share capital, being 22,513,553 ordinary shares of 25p. This authority will expire at the conclusion of the AGM to be held in 2024, unless previously renewed, varied or revoked.

 

The full text of all the resolutions can be found in the Notice of Annual General Meeting contained in the Annual Report and Financial Statements which is available for viewing at the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

 

Baillie Gifford & Co Limited

Company Secretaries

7 September 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings